Common stock issued as advisory fee for bridge note financing
Company: Core Scientific
The claim, verbatim
386,697 shares were issued to B. Riley Securities as an advisory fee in connection with two amended and restated bridge promissory notes
Source (primary)
Core Scientific 424B3 filed 2022-10-31 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “The Advisory Fee Shares included in the Prospectus consist of shares of Common Stock that we have issued to BRS as an advisory fee in connection with our execution of two amended and restated bridge promissory notes on August 1, 2022, one with B. Riley Commercial Capital, LLC and one with an affiliate of B. Riley Commercial Capital, LLC”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document states the 386,697 advisory fee shares to BRS in connection with the two bridge notes.
Confirmed in the source:
- 386,697 shares were issued to B. Riley Securities as an advisory fee
- The fee relates to two amended and restated bridge promissory notes
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522274014/d416148d424b3.htm) in full (11,077 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-31
Quote: “The Advisory Fee Shares included in the Prospectus consist of shares of Common Stock that we have issued to BRS as an advisory fee in connection with our execution of two amended and restated bridge promissory notes on August 1, 2022, one with B. Riley Commercial Capital, LLC and one with an affiliate of B. Riley Commercial Capital, LLC”